The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses by Claudio Scuoppo, Rick Ramirez, Siok F. Leong, Mark Koester, Zachary F. Mattes, Karen Mendelson, Julia Diehl, Franco Abbate, Erin Gallagher, Lila Ghamsari, Abi Vainstein-Haras, Gene Merutka, Barry J. Kappel, Jim A. Rotolo

Get full text